Brief: Xspray Pharma To Advance Fourth Product Candidate XS015 Into Clinical Trials
22/04/2024 15:17
April 22 (Reuters) - XSpray Pharma AB (publ)
XSPRAY.ST :
* STRATEGIC DECISION TO ADVANCE ITS FOURTH PRODUCT CANDIDATE
XS015
INTO CLINICAL TRIALS
* IS CURRENTLY IN FINAL PHASE OF PREPARATION FOR ANTICIPATED
LAUNCH OF ITS FIRST PRODUCT, DASYNOCTM, ON SEPTEMBER 1, 2024
PENDING FINAL FDA APPROVAL
Source text for Eikon: ID:nMFN5x19tq
Further company coverage: XSPRAY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))